F016 The Art of Healing- Scar Management Strategies Tailored to Ethnic Skin
DESCRIPTION
This interactive, Case-Based Approach to Scar Management session will explore the challenges of treating different types of scars in skin of color. Clinical cases will highlight differences across skin types, including pigmentation responses, scarring patterns, treatment strategies, and potential complications.
Each block will feature two speakers on stage, each presenting one case using only three slides:
1. Before: Clinical photograph, relevant history, and therapeutic dilemma.
2. Treatment: What was done and the clinical reasoning.
3. Before and after: Comparative photographs and treatment outcomes.
Scientific Program | 1:00–3:00 PM
1:00–1:18 PM | Burn Scars
Presenters: Michael H. Gold, MD & Alexandre Filippo, MD
1:18–1:36 PM | Acne Scars
Presenters: Alex Zhang, MD & Daniela Guzmán-Sánchez, MD
1:36–1:54 PM | Keloids and Scar Prevention
Presenters: Gisele Viana de Oliveira, MD, PhD & Keyvan Nouri, MD
1:54–2:12 PM | Hypertrophic Scars
Presenters: Andrés Luque, MD & Ariel Haus, MD
2:12–2:30 PM | Atrophic Linear Scars
Presenters: Henry H. L. Chan, MD, PhD & Brunilda Bardi, MD
2:30–2:48 PM | The Final Touch: Scar Refinement with Fillers and Pigmentation Management
Presenters: Doris Hexsel, MD & Denise Steiner, MD, PhD
We will close our session with a discussion of all these approaches with the audience.
LEARNING OBJECTIVES
Recognize the features that shape scar treatment in skin of color, including scar morphology, pigmentary responses, and the risk of treatment-related complications.
Design individualized, evidence-informed treatment strategies for challenging scars by integrating medical therapies, energy-based devices, and scar refinement techniques.
Critically compare approaches and outcomes through interactive case discussions, translating expert insights into practical decisions that improve scar appearance, function, and patient quality of life
SCHEDULE
1:00 PM
Burn Scars
Alexandre De Almeida Filippo, MD, IFAAD
1:18 PM
Acne Scars
Daniela Araucaria Guzman Sanchez, MD, IFAAD, Alexandra Y. Zhang, MD, FAAD
1:30 PM
Discussion
1:30 PM
Discussion
1:36 PM
Keloids and Scar Prevention
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD, Keyvan Nouri, MBA, MD, FAAD
1:36 PM
Hypertrophic Scars
Ariel Haus, MD, IFAAD, Alvaro Andres Luque Acevedo, MD, IFAAD
2:12 PM
Atrophic Linear Scars
Brunilda Bardhi, MD, IFAAD, Henry H.L. Chan, MD, PhD, IFAAD
2:30 PM
Scar Refinement with Fillers and Pigmentation Management
Doris M. Hexsel, MD, IFAAD
DIRECTOR
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
Faculdade de Ciencias Medicas de Minas Gerais, Brazil
SPEAKERS
Brunilda Bardhi, MD, IFAAD
Venusderm Clinic
Henry H.L. Chan, MD, PhD, IFAAD
Alexandre De Almeida Filippo, MD, IFAAD
Santa Casa Hospital in Rio de Janeiro
Daniela Araucaria Guzman Sanchez, MD, IFAAD
Ariel Haus, MD, IFAAD
Doris M. Hexsel, MD, IFAAD
Hexsel Dermatologic Clinics - Private Clinics Rio de Janeiro and Porto Alegre, Brazil.
Alvaro Andres Luque Acevedo, MD, IFAAD
• Member of the Colombian Association of Dermatology and Dermatologic Surgery - ASOCOLDERMA • Fellow of the American Academy of Dermatology - AAD • Member of the Ibero-American College of Dermatologists – CILAD • Member of the Brazilian Society of Dermatology - SBD • Fellow of the European Academy of Dermatology and Venereology – EADV • Fellow of the American Society for Laser Medicine and Surgery – ASLMS / Centro Dermatologico Federico LLeras Acosta - Bogotá - Colombia
Keyvan Nouri, MBA, MD, FAAD
Alexandra Y. Zhang, MD, FAAD
DISCLOSURES
Brunilda Bardhi, MD, IFAAD
No financial relationships exist with ineligible companies.
Henry H.L. Chan, MD, PhD, IFAAD
AbbVie Inc – Consultant (1099 relationship)(Fees); AVAVA, LLC – Founder(Stock Options); Blossom Innovations, LLC – Board of Directors(Stock Options); Boehringer Ingelheim – Advisory Board(Honoraria); Clarity Cosmetics, Inc. – Stockholder Private Company(Stock Options); Cutera, Inc. – Other(Equipment); Cynosure, Inc. – Investigator(Other Financial Benefit); Cytrellis Biosystems, Inc – Stockholder Private Company(Stock); Eli Lilly Asia Inc – Speaker/Faculty Education(Honoraria); Massachusetts General Hospital – Employee (w-2 relationship)(Patent royalties or other compensation for Intellectual Property Rights); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); R2 Dermatology, Inc. – Investigator(Other Financial Benefit); Sofwave – Investigator(Fees); Solta Medical Hong Kong Ltd – Speaker/Faculty Education(Honoraria); UCB Pharma (Hong Kong) Ltd – Advisory Board(Fees);
Alexandre De Almeida Filippo, MD, IFAAD
No financial relationships exist with ineligible companies.
Daniela Araucaria Guzman Sanchez, MD, IFAAD
Clinique – Advisory Board(Other Financial Benefit); DS Laboratories – Speaker(Honoraria); KPI Therapeutics, Inc. – Speaker(No Compensation Received); Omicron Lab – Investigator(Grants/Research Funding); Panalab – Speaker(Honoraria); Pierre Fabre – Speaker(Honoraria);
Ariel Haus, MD, IFAAD
No financial relationships exist with ineligible companies.
Doris M. Hexsel, MD, IFAAD
Baiersdorf Eucerin – Speaker(Fees); Galderma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Rennova – Speaker(Fees);
Alvaro Andres Luque Acevedo, MD, IFAAD
No financial relationships exist with ineligible companies.
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
LMG – Speaker(Other Financial Benefit); Vydence Medical – Speaker(Other Financial Benefit);
Alexandra Y. Zhang, MD, FAAD
No financial relationships exist with ineligible companies.